Literature DB >> 30993422

Risk of mesothelioma after cessation of asbestos exposure: a systematic review and meta-regression.

Paolo Boffetta1,2, Francesca Donato3, Enrico Pira3, Hung N Luu4,5, Carlo La Vecchia6.   

Abstract

PURPOSE: A 'risk reversal' has been observed for several human carcinogens following cessation of exposure, but it is unclear whether it also exists for asbestos-related mesothelioma.
METHODS: We conducted a systematic review of the literature and identified nine studies that reported information on risk of mesothelioma after cessation of asbestos exposure, and performed a meta-regression based on random effects models. As comparison we analyzed results on lung cancer risk from four of these studies.
RESULTS: A total of six risk estimates from five studies were included in the meta-analysis. The summary relative risk (RR) of mesothelioma for 10-year interval since cessation of exposure was 1.02 [95% confidence interval (CI) 0.87-1.19; p-heterogeneity 0.01]. The corresponding RR of lung cancer was 0.91 (95% CI 0.84-0.98).
CONCLUSIONS: This analysis provides evidence that the risk of mesothelioma does not decrease after cessation of asbestos exposure, while lung cancer risk does.

Entities:  

Keywords:  Asbestos; Mesothelioma; Time since last exposure

Mesh:

Substances:

Year:  2019        PMID: 30993422     DOI: 10.1007/s00420-019-01433-4

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  26 in total

1.  The risk of lung cancer and mesothelioma after cessation of asbestos exposure: a prospective cohort study of shipyard workers.

Authors:  A Sandén; B Järvholm; S Larsson; G Thiringer
Journal:  Eur Respir J       Date:  1992-03       Impact factor: 16.671

Review 2.  Mechanisms in the pathogenesis of asbestosis and silicosis.

Authors:  B T Mossman; A Churg
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

3.  Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy.

Authors:  P Boffetta; L Righi; C Ciocan; C Pelucchi; C La Vecchia; C Romano; M Papotti; E Pira
Journal:  Ann Oncol       Date:  2018-02-01       Impact factor: 32.976

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe.

Authors:  Paul Brennan; Anna Crispo; David Zaridze; Neonila Szeszenia-Dabrowska; Peter Rudnai; Jolanta Lissowska; Eleonóra Fabiánová; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Tony Fletcher; Paolo Boffetta
Journal:  Am J Epidemiol       Date:  2006-10-10       Impact factor: 4.897

6.  Asbestosis and mesothelioma among British asbestos workers (1971-2005).

Authors:  Anne-Helen Harding; Andrew J Darnton
Journal:  Am J Ind Med       Date:  2010-11       Impact factor: 2.214

7.  Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos.

Authors:  Beate Pesch; Dirk Taeger; Georg Johnen; Isabelle M Gross; Daniel G Weber; Monika Gube; Alice Müller-Lux; Evelyn Heinze; Thorsten Wiethege; Volker Neumann; Andrea Tannapfel; Hans-Jürgen Raithel; Thomas Brüning; Thomas Kraus
Journal:  Int J Hyg Environ Health       Date:  2009-09-26       Impact factor: 5.840

8.  Mortality of chrysotile asbestos workers at the Balangero Mine, Northern Italy.

Authors:  G F Rubino; G Piolatto; M L Newhouse; G Scansetti; G A Aresini; R Murray
Journal:  Br J Ind Med       Date:  1979-08

9.  Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia.

Authors:  G Berry; N H de Klerk; A Reid; G L Ambrosini; L Fritschi; N J Olsen; E Merler; A W Musk
Journal:  Occup Environ Med       Date:  2004-04       Impact factor: 4.402

10.  Updated mortality study of a cohort of asbestos textile workers.

Authors:  Enrico Pira; Canzio Romano; Francesco S Violante; Andrea Farioli; Giovanna Spatari; Carlo La Vecchia; Paolo Boffetta
Journal:  Cancer Med       Date:  2016-07-25       Impact factor: 4.452

View more
  4 in total

1.  Cytogenomic characterization of three murine malignant mesothelioma tumor cell lines.

Authors:  Eva Wahlbuhl; Thomas Liehr; Martina Rincic; Shaymaa Azawi
Journal:  Mol Cytogenet       Date:  2020-09-09       Impact factor: 2.009

2.  Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden.

Authors:  Kari Hemminki; Asta Försti; Tianhui Chen; Akseli Hemminki
Journal:  BMC Cancer       Date:  2021-11-08       Impact factor: 4.430

3.  Novel and Future Treatment Options in Mesothelioma: A Systematic Review.

Authors:  Danijela Štrbac; Vita Dolžan
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

4.  Matrix Metalloproteinases as Biomarkers and Treatment Targets in Mesothelioma: A Systematic Review.

Authors:  Danijela Štrbac; Vita Dolžan
Journal:  Biomolecules       Date:  2021-08-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.